significant interaction has just been identified between gemfibrozil (Lopid, etc) and repaglinide (Prandin)

June 2003

A significant interaction has just been identified between gemfibrozil (Lopid, etc) and repaglinide (Prandin).

These drugs are likely to be used together. Many diabetes patients get gemfibrozil to lower triglycerides and increase HDL.

Now there's evidence that gemfibrozil can inhibit a cytochrome P450 enzyme that metabolizes repaglinide.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

any blood pressure over 115/75 increases the risk of death from heart disease and stroke
Diabetes significant interaction has just been identified between gemfibrozil (Lopid, etc) and repaglinide (Prandin)
Obesity & Weight Loss people are asking about the best ways to lose weight
Cardiology Should sublingual nitroglycerin (SL NTG) tablets be discarded 6 months after opening the bottle?
Cardiology using high-dose folate, B6, and B12 supplements after angioplasty
Women's Health Prempro INCREASES the risk of dementia and urinary incontinence
Women's Health lower strength of Premarin and Prempro
Contraceptives Plan B (levonorgestrel) can be given in just ONE dose for emergency contraception
Bell's Palsy how to treat Bell's palsy
Anticoagulants aspirin instead of warfarin to prevent stroke in patients with nonvalvular atrial fibrillation
Anticoagulants 10 mg "loading dose" when starting warfarin in outpatients with venous thromboembolism
Hematology & Oncology whether garlic can prevent cancer
Hematology & Oncology New cancer drugs are making headlines
Dermatology new OTC wart remover called Wartner